Disease Modification for Parkinson's Disease: Axonal Regeneration and Trophic Factors
出版年份 2018 全文链接
标题
Disease Modification for Parkinson's Disease: Axonal Regeneration and Trophic Factors
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 33, Issue 5, Pages 678-683
出版商
Wiley
发表日期
2018-03-31
DOI
10.1002/mds.27383
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models
- (2017) Xiaomin Su et al. MOLECULAR THERAPY
- Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
- (2017) Ken Y Chan et al. NATURE NEUROSCIENCE
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
- (2015) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Cell-based therapies for Parkinson disease—past insights and future potential
- (2015) Roger A. Barker et al. Nature Reviews Neurology
- Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies
- (2015) R.T. Bartus et al. NEUROBIOLOGY OF DISEASE
- Treatment of Parkinson's disease using cell transplantation
- (2015) Olle Lindvall PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Rebuilding the nigrostriatal dopamine pathway: 30 years and counting
- (2014) Timothy J. Collier EXPERIMENTAL NEUROLOGY
- The Neurology of mTOR
- (2014) Jonathan O. Lipton et al. NEURON
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Trophic Factor Gene Therapy for Parkinson's Disease
- (2013) Jeffrey H. Kordower et al. MOVEMENT DISORDERS
- Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration
- (2011) Sang Ryong Kim et al. ANNALS OF NEUROLOGY
- Neuronal Intrinsic Mechanisms of Axon Regeneration
- (2011) Kai Liu et al. Annual Review of Neuroscience
- AAV Transduction of Dopamine Neurons With Constitutively Active Rheb Protects From Neurodegeneration and Mediates Axon Regrowth
- (2011) Sang Ryong Kim et al. MOLECULAR THERAPY
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors
- (2010) Xiaomin Su et al. MOLECULAR THERAPY
- PTEN deletion enhances the regenerative ability of adult corticospinal neurons
- (2010) Kai Liu et al. NATURE NEUROSCIENCE
- Establishment of Axon-Dendrite Polarity in Developing Neurons
- (2009) Anthony P. Barnes et al. Annual Review of Neuroscience
- Involvement of Akt in neurite outgrowth
- (2009) Danielle E. Read et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain
- (2009) Lachlan H. Thompson et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants
- (2009) Afsaneh Gaillard et al. NEUROBIOLOGY OF DISEASE
- JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration
- (2008) Vincent Ries et al. JOURNAL OF NEUROCHEMISTRY
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
- (2008) K. K. Park et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More